Exscientia PLC
(NAS:EXAI)
$
5.04
-0.16 (-3.08%)
Market Cap: 640.18 Mil
Enterprise Value: 281.73 Mil
PE Ratio: 0
PB Ratio: 1.66
GF Score: 40/100 
Exscientia PLC at Bank of America Merrill Lynch Global Healthcare Conference Transcript
Sep 15, 2022 / 02:05PM GMT
Release Date Price:
$8.91
(-5.41%)
Michael Leonidovich Ryskin
BofA Securities, Research Division - Director in Equity Research & Research Analyst
For our next session. My name is Mike Ryskin. I'm on the BofA Life Science Tools and Diagnostics team.
And for our next slide, we're joined by Exscientia. And with us we have Andrew Hopkins, Garry Pairaudeau and Mike Krams. Gentlemen, thank you.
Andrew L. Hopkins
Exscientia plc - Founder, CEO & Executive Director
Great to be here, Mike.
Questions & Answers
Michael Leonidovich Ryskin
BofA Securities, Research Division - Director in Equity Research & Research Analyst
Maybe just to set the floor a little bit. I think, given you're still a recent IPO, we always like to start with maybe a little bit of background, kind of -- tell us about yourself, tell us about the company, and sort of where you fit in?
Andrew L. Hopkins
Exscientia plc - Founder, CEO & Executive Director
Excellent. Thanks for the opportunity to be here today,
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers